Photo: partnering meetings at BIO 2018. 6th, June 2018 PROALT has participated in the partnering event at BIO International Convention in Boston, MA (USA), to present the latest advances of COLODETECT, the non-invasive test in development by the company that will allow early detection of colorectal cancer (CCR) in patients affected by this disease, even [...]

14th, March 2018 BIOEUROPE SPRING 2018 is the premier springtime partnering conference for the biotechnology industry. Amsterdam, The Netherlands. 12th-14th March 2018. The company participated in the conference and partnering event to promote its activities in colorectal cancer diagnostic and therapeutic fields, highlighting the latest progresses. Investors had the chance to update about the of [...]

Photo: Dr. Thomas Zürcher, R&D Project Leader, during PROALT presentation in investors session: Novel approaches for the diagnosis and treatment of colorectal cancer. 26th, February 2018 PROTEIN ALTERNATIVES attended the 11th Annual European Life Sciences CEO Forum & Exhibition for Partnering & Investing in Biotech & Pharma Industry. The event was organized by Sachs Associates [...]

Photo: Dr. Juan I. Imbaud. Poster session B47 26th, October 2017 PROALT attends AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. During the event, organized in Philadelphia (PA) from 26th to 30th October, Dr Juan Ignacio Imbaud, the company Director, exposed a poster that showed the latest results of [...]